T2 Biosystems, Inc.·4

Feb 23, 6:29 PM ET

Sperzel John J III 4

4 · T2 Biosystems, Inc. · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-20
Sperzel John J III
DirectorSee Remarks
Transactions
  • Award

    Restricted Stock Units

    2022-02-20+2,400,0002,400,000 total
    Common Stock (2,400,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The restricted stock units vest in three equal annual installments commencing on February 20, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION